Orbitrap Astral Mass Spectrometerr to the Proteomics Research Infrastructure (PRI)

Description

Proteomics Research Infrastructure (PRI) is a state of-the-art mass spectrometry (MS)-based proteomics facility. Founded on 1 July 2020, the new facility provides coordinated, proprietary client access to forerunner proteomic technology, exceptional technical assistance, and streamlined bioinformatic data analysis for the local research community. PRI is funded by the Novo Nordisk Foundation (NNF) and linked to the NNF Center for Protein Research at the University of Copenhagen. Lot 1: The purchase is to add an additional instrument to the already existing installation, in the research facility at the University of Copenhagen. The procurement is to support the application in research and development, in basic research and applied research in proteomics. This notice is sent in continuation of the University of Copenhagen's voluntary ex ante transparency notice no. 2023/S 239-751056 where University of Copenhagen published its intention to enter into the contract with Thermo Fisher Scientific. After the expiry of 10 calendar days calculated from the day after the date where the voluntary ex ante transparency notice was published, see section 4(1), para 2, of the Danish Act on the Complaints Board for Public Procurement, the University of Copenhagen has entered into the contract with Thermo Fisher Scientific. Regarding section II.2.5) and V.2.2) it is noted that this procurement has been subject to a negotiated procedure without prior publication. Reference is made to the reasoning in section IV.1.1) and the voluntary ex ante transparency notice referred in section IV.2.1). Therefore, only one tender was received.